Word

Status

Registered

Status Code

700

Status Date

Tuesday, August 9, 2022

Serial Number

90647331

Registration Number

6816378

Registration Date

Tuesday, August 9, 2022

Mark Type

2000

Filing Date

Thursday, April 15, 2021

Published for Opposition

Tuesday, October 19, 2021

Trademark Owner History

BeiGene, Ltd. - Original Registrant

Classifications

40 Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

5 Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

44 Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice

42 Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design

The mark consists of a shaded square in red with a stylized square and a star in the center of the stylized square.
The color(s) red is/are claimed as a feature of the mark.

Trademark Events

Mar 24, 2023

Teas Change Of Correspondence Received

Mar 24, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 24, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 8, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 8, 2022

Teas Change Of Correspondence Received

Dec 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 8, 2022

Teas Change Of Owner Address Received

Aug 9, 2022

Notice Of Registration Confirmation Emailed

Aug 9, 2022

Registered-Principal Register

Jul 8, 2022

Notice Of Acceptance Of Statement Of Use E-Mailed

Jul 7, 2022

Allowed Principal Register - Sou Accepted

Jun 1, 2022

Data Modification Completed

Jun 1, 2022

Assigned To Lie

May 26, 2022

Statement Of Use Processing Complete

May 12, 2022

Use Amendment Filed

May 26, 2022

Case Assigned To Intent To Use Paralegal

May 26, 2022

Case Assigned To Intent To Use Paralegal

May 12, 2022

Teas Statement Of Use Received

Dec 14, 2021

Noa E-Mailed - Sou Required From Applicant

Oct 19, 2021

Official Gazette Publication Confirmation E-Mailed

Oct 19, 2021

Published For Opposition

Sep 29, 2021

Notification Of Notice Of Publication E-Mailed

Sep 13, 2021

Approved For Pub - Principal Register

Sep 8, 2021

Assigned To Examiner

Jul 23, 2021

Notice Of Design Search Code E-Mailed

Jul 22, 2021

New Application Office Supplied Data Entered

Apr 19, 2021

New Application Entered